Founder and CEO
PL
Phi Life Sciences
This startup provides molecular diagnostic and laboratory services that utilize a bench-to-bedside approach to enhance the efficiency and accessibility of molecular testing. By enabling early disease detection through precise diagnostic tools, the company aims to reduce disease mortality and adverse drug reactions in patients.
- Biotechnology
- Healthcare Technology
Updated 21 months ago
Funding
Raised to date
$200KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This startup provides molecular diagnostic and laboratory services that utilize a bench-to-bedside approach to enhance the efficiency and accessibility of molecular testing. By enabling early disease detection through precise diagnostic tools, the company aims to reduce disease mortality and adverse drug reactions in patients.